Norwood Eye Care Specialists, Llc | |
825 Washington St Ste 230, Norwood, MA 02062-3488 | |
(781) 769-8880 | |
(781) 769-2850 |
Full Name | Norwood Eye Care Specialists, Llc |
---|---|
Type | Facility |
Speciality | Optometrist - Corneal And Contact Management |
Location | 825 Washington St Ste 230, Norwood, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942965421 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152WC0802X | Optometrist - Corneal And Contact Management | (* (Not Available)) | Primary |
Provider Name | George T Frangieh |
---|---|
Provider Type | Practitioner - Ophthalmology |
Provider Identifiers | NPI Number: 1659303113 PECOS PAC ID: 0941257687 Enrollment ID: I20050405000350 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Provider Name | Bruce H Micley |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1689775710 PECOS PAC ID: 3577651009 Enrollment ID: I20071117000054 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Provider Name | Marisa Palumbo |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1982869988 PECOS PAC ID: 7012056765 Enrollment ID: I20091209000405 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Provider Name | Talish Aghababayan |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1386157576 PECOS PAC ID: 8224396247 Enrollment ID: I20171221001050 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Provider Name | Haben F Kefella |
---|---|
Provider Type | Practitioner - Ophthalmology |
Provider Identifiers | NPI Number: 1629498290 PECOS PAC ID: 1052530771 Enrollment ID: I20180612000817 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Provider Name | Mehdi Najafi |
---|---|
Provider Type | Practitioner - Ophthalmology |
Provider Identifiers | NPI Number: 1003252297 PECOS PAC ID: 2567749849 Enrollment ID: I20190429001656 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Provider Name | Huan Mills |
---|---|
Provider Type | Practitioner - Ophthalmology |
Provider Identifiers | NPI Number: 1649633215 PECOS PAC ID: 1254604374 Enrollment ID: I20200821001849 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Norwood Eye Care Specialists, Llc 825 Washington St Ste 230, Norwood, MA 02062-3488 Ph: (781) 769-8880 | Norwood Eye Care Specialists, Llc 825 Washington St Ste 230, Norwood, MA 02062-3488 Ph: (781) 769-8880 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
The protein, MDM2, normally functions to control the activity of a key cancer preventing protein called p53.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.
› Verified 7 days ago
Dr. Steven Sharma, O.D Optometrist Medicare: Medicare Enrolled Practice Location: 31 Boston Providence Tpke, Lenscrafters Building, Norwood, MA 02062 Phone: 781-769-9290 | |
H. David Tabaie, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 95 Chapel St, First Floor, Norwood, MA 02062 Phone: 781-762-9018 Fax: 781-762-8878 | |
Graham Stetson, OD, MS Optometrist Medicare: Accepting Medicare Assignments Practice Location: 696 Washington St, Norwood, MA 02062 Phone: 781-352-4849 Fax: 781-634-8352 | |
Dr. Nabeel Khudairi, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 54 Cottage St E, Norwood, MA 02062 Phone: 781-762-5455 | |
Dr. Leigh C Kozak, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 95 Chapel St, Medical Eye Care Associates, Norwood, MA 02062 Phone: 781-333-2222 | |
Medical Eye Care Associates, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 95 Chapel St, Norwood, MA 02062 Phone: 781-762-9018 Fax: 781-762-0118 | |
Robert M. Condon, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 95 Chapel St, First Floor, Norwood, MA 02062 Phone: 781-762-9018 Fax: 781-762-8878 |